This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

22 - 24 September 2020|★ VIRTUAL EVENT, (All-Digital Format)

Propel Global Disclosure, Publication and Medical Communication Success

Proven strategies to ensure clinical trial data is on the pulse of global regulatory requirements, reported accurately, redacted appropriately and achieves meaningful patient engagement from study start-up through post-market publications.

Take Advantage of our Advanced Pricing Discount...

Register by 28 August 2020 and Save $200!

Introduction Video


by Alexandra Spica

Interested in speaking opportunities?
Contact Allie for information.

+1-339-298-2250

alexandra.spica@informa.com

Redefining Your Learning Experience

In light of the current global climate, it is more important than ever for the publication & transparency community to connect with one another, strategize and share ideas – All in a safe, responsible way. With our dedication to address the most pressing issues, the 9th Annual Publication & Clinical Trial Transparency, taking place 22 - 24 September, has undergone a timely transformation, moving to an all-digital format and offering attendees the ability to participate in virtual content, exhibits and networking opportunities.


UNIQUE BENEFITS OF THIS VIRTUAL EVENT:
UNIQUE BENEFITS OF THIS VIRTUAL EVENT:
  • Customizable agenda with access to expanded session offerings
  • Convenient session scheduling for increased productivity
  • On-demand access to content and topic resources
  • Interactive presentations/panels for reinforced learning
  • Pointed problem-solving and solution sourcing
  • Broader industry benchmarking and post-event analytics/insights
  • Elevated and direct access to thought-leaders and experts
POWER OF NETWORKING:
POWER OF NETWORKING:

Who’s Who?

  • Attendee and company profiles provide insight into the delegation and sponsoring organizations
  • Advanced search capabilities to identify opportunities and potential partners

When and How to Connect?

  • Sophisticated and seamless scheduling tools to establish meeting times
  • Ease-of-use technology to enable virtual networking
COMPREHENSIVE CONTENT AND DIGITAL CAPABILITIES:
COMPREHENSIVE CONTENT AND DIGITAL CAPABILITIES:
  • Days of Live Content from Industry Thought Leaders
  • 10+ On-Demand Sessions
  • Over 4 Hours of Live Speaker Q&A and Interactive Content
  • Networking with Colleagues and Counterparts
  • Audience Q&A
  • Live Polling
  • Expert-Led Problem-Solving
  • Private Meeting and Chat Rooms

Who Should Attend

You will benefit from attending this event if you are from a bio/pharmaceutical or medical device company with responsibilities or involvement in the following areas:


  • Clinical Trial Transparency
  • Clinical Trial Disclosure
  • Publications
  • Medical Writing
  • Data Anonymisation
  • Data Sharing
  • Clinical Trial Registries
  • Medical Affairs
  • Patient Level Data

This event would also benefit consultants, CROs and companies that offer services for clinical trial transparency, publication planning and medical writing.

IN-DEPTH, ON-DEMAND WORKSHOPS — WHAT YOU WANT. WHEN YOU WANT IT. ◎

There is much to experience and meet about at the 9th Annual Publication & Clinical Trial Transparency. On-Demand content is available anytime, to accommodate your needs and schedule.

PATIENT PERSPECTIVE ● Optimising Outcomes for Patients — Ensuring Centricity and Transparency 

Helen Bulbeck

Share Challenges and Lessons Learned in Global Clinical Trial Data Disclosure 

Barbara A. Kress


Advance UK Transparency and Assess the Potential Implications of Brexit 

Amanda Hunn

EMA Policy 0070 — An Exploratory Review of Data Utility in Clinical Study Reports for Academic Research 

Sarah Nevitt


Establish Strategic Timelines for Publication Development and Develop Documents with the End in Mind 

Colin McKinnon

Making Clinical Study Results More Accessible — The Use of Graphics in Lay Summaries 

Thomas Schindler


Early Experience With Ukraine’s Move Towards Transparency of Clinical Trials Data 

Merete Joergensen

Drug Device Combination (DDC) Products 

Maren von Fritschen


Real-World Evidence and HEOR Strategic Communications 

Speaker TBA

Clinical Trial Disclosure Requirements in the EU Medical Device Regulation and Upcoming Revision of EN ISO 14155 

Matthias Zerm, PhD

Connect and Network with Key Decision-Makers at Publication & Clinical Trial Transparency

Whether you’re looking to generate quality leads, showcase thought leaders, or reinforce your brand, collaborate with us to identify custom sponsorship opportunities to help you reach your business objectives.

For more information about opportunities to reach a qualified audience, contact LifeSciencePartners@informaconnectls.com.